{"id":"https://openalex.org/W2323355271","doi":"https://doi.org/10.1097/00002030-200409240-00008","title":"Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients","display_name":"Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients","publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W2323355271","doi":"https://doi.org/10.1097/00002030-200409240-00008","mag":"2323355271","pmid":"https://pubmed.ncbi.nlm.nih.gov/15353978"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200409240-00008","doi":"https://doi.org/10.1097/00002030-200409240-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200409240-00008","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113605022","display_name":"Sanjay U.C. Sankatsing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Sanjay U C Sankatsing","raw_affiliation_strings":["Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, University of Amsterdam, The Netherlands","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, University of Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I887064364"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072335510","display_name":"Suzanne Jurriaans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Suzanne Jurriaans","raw_affiliation_strings":["Department of Human Retrovirology, Academic Medical Center and the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Retrovirology, Academic Medical Center and the","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111365695","display_name":"Peter van Swieten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter van Swieten","raw_affiliation_strings":["Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","institution_ids":["https://openalex.org/I3020210244","https://openalex.org/I887064364"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059234144","display_name":"Frank van Leth","orcid":"https://orcid.org/0000-0002-5490-8968","observed_orcids":["https://orcid.org/0000-0002-5490-8968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank van Leth","raw_affiliation_strings":["International Antiviral Therapy Evaluation Center (IATEC), Amsterdam, the Netherlands","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Antiviral Therapy Evaluation Center (IATEC), Amsterdam, the Netherlands","institution_ids":[]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040356812","display_name":"Marion T. E. Cornelissen","orcid":"https://orcid.org/0000-0001-8510-3698","observed_orcids":["https://orcid.org/0000-0001-8510-3698"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marion Cornelissen","raw_affiliation_strings":["Department of Human Retrovirology, Academic Medical Center and the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Retrovirology, Academic Medical Center and the","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069161180","display_name":"Frank F. Miedema","orcid":"https://orcid.org/0000-0002-8063-5799","observed_orcids":["https://orcid.org/0000-0002-8063-5799","https://orcid.org/0009-0002-2183-3880"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Frank Miedema","raw_affiliation_strings":["Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","institution_ids":["https://openalex.org/I3020210244","https://openalex.org/I887064364"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113507629","display_name":"Joep M. A. Lange","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joep M A Lange","raw_affiliation_strings":["Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, the","International Antiviral Therapy Evaluation Center (IATEC), Amsterdam, the Netherlands","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, the","institution_ids":[]},{"raw_affiliation_string":"International Antiviral Therapy Evaluation Center (IATEC), Amsterdam, the Netherlands","institution_ids":[]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014967648","display_name":"Hanneke Schuitemaker","orcid":"https://orcid.org/0000-0001-8563-2266","observed_orcids":["https://orcid.org/0000-0001-8563-2266"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hanneke Schuitemaker","raw_affiliation_strings":["Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical ViroImmunology, CLB Sanquin and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, and the","institution_ids":["https://openalex.org/I3020210244","https://openalex.org/I887064364"]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047002646","display_name":"Jan M. Prins","orcid":"https://orcid.org/0000-0002-5415-8933","observed_orcids":["https://orcid.org/0000-0002-5415-8933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan M Prins","raw_affiliation_strings":["Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, the","to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, the","institution_ids":[]},{"raw_affiliation_string":"to S. U. C. Sankatsing, International Antiviral Therapy Evaluation Center (IATEC), T0-111, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113605022"],"corresponding_institution_ids":["https://openalex.org/I887064364"],"apc_list":null,"apc_paid":null,"fwci":1.74,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.84079463,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"14","first_page":"1925","last_page":"1931"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8809999823570251},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.8220000267028809},{"id":"https://openalex.org/keywords/latent-viral-reservoir","display_name":"latent viral reservoir","score":0.7710000276565552},{"id":"https://openalex.org/keywords/primary-hiv-infection","display_name":"primary HIV infection","score":0.7870000004768372},{"id":"https://openalex.org/keywords/chronic-hiv-infection","display_name":"chronic HIV infection","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.8684393763542175},{"id":"https://openalex.org/C2909935303","wikidata":"https://www.wikidata.org/wiki/Q420553","display_name":"Mycophenolate","level":3,"score":0.7492818236351013},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6501163244247437},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6491162776947021},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5993974208831787},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5292127728462219},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47182899713516235},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.4295557737350464},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4184149205684662},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4105561673641205},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3900868892669678},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.327653169631958},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.31026625633239746},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.17096048593521118}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/00002030-200409240-00008","doi":"https://doi.org/10.1097/00002030-200409240-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200409240-00008","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:15353978","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15353978","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/3a59b54e-e56b-4f8a-a419-5e8a8c0e4ff1","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/highly-active-antiretroviral-therapy-with-or-without-mycophenolate-mofetil-in-treatmentnaive-hiv1-patients(3a59b54e-e56b-4f8a-a419-5e8a8c0e4ff1).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS (London, England), 18(14), 1925 - 1931. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/2085b4ae-6d48-4411-9b51-fec0c426e8b7","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2085b4ae-6d48-4411-9b51-fec0c426e8b7","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Sankatsing, S U C, Jurriaans, S, van Swieten, P, van Leth, F, Cornelissen, M, Miedema, F, Lange, J M A, Schuitemaker, H & Prins, J M 2004, 'Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients', AIDS (London, England), vol. 18, no. 14, pp. 1925-1931. https://doi.org/10.1097/00002030-200409240-00008","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1497870368","https://openalex.org/W1520782722","https://openalex.org/W1605101705","https://openalex.org/W1978518017","https://openalex.org/W2001423525","https://openalex.org/W2004246558","https://openalex.org/W2011626958","https://openalex.org/W2016273346","https://openalex.org/W2018768428","https://openalex.org/W2030844138","https://openalex.org/W2031037912","https://openalex.org/W2051269276","https://openalex.org/W2054457785","https://openalex.org/W2060829964","https://openalex.org/W2066409312","https://openalex.org/W2090646713","https://openalex.org/W2103325552","https://openalex.org/W2139250164","https://openalex.org/W2156917454","https://openalex.org/W2158562439","https://openalex.org/W2159296257","https://openalex.org/W2164273972","https://openalex.org/W2164864370","https://openalex.org/W2319657764","https://openalex.org/W2327715786","https://openalex.org/W2329745947"],"related_works":["https://openalex.org/W2001423525","https://openalex.org/W2034659049","https://openalex.org/W2154369547","https://openalex.org/W2324813721","https://openalex.org/W4309407233","https://openalex.org/W1980794380","https://openalex.org/W4241906316","https://openalex.org/W2003655730","https://openalex.org/W2040514396","https://openalex.org/W1977465147"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"study":[2],"the":[3,10,18,95,100,213,239,246,250],"effect":[4],"of":[5,13,36,83,104,170,218,224,249],"mycophenolate":[6],"mofetil":[7],"(MMF)":[8],"on":[9],"decay":[11,91,114,168,243,247],"rate":[12,115,169,244,248],"plasma":[14,84,110,240],"HIV-1":[15,38,69,80,85,111,241],"RNA":[16,70,86,112,242],"and":[17,45,73,87,99,130,154,176,184,202],"latently":[19,171,251],"infected":[20,39,118,143,172,178,252],"cellular":[21,88,214,253],"reservoir":[22,215],"in":[23,116,141,181,193,212,216,232],"treatment-naive":[24,233],"patients":[25,40,119,182,200,234],"starting":[26,51],"antiretroviral":[27,54,230],"therapy.":[28],"DESIGN:":[29],":":[30],"Randomized":[31],"trial.":[32],"METHODS:":[33],"A":[34],"group":[35,61],"19":[37],"(9":[41],"with":[42,47,62,128,152,183,201],"a":[43,48,52,60,227],"chronic":[44],"10":[46],"primary":[49,142],"infection)":[50],"triple":[53,228],"drug":[55],"regimen":[56,231],"were":[57,71,77,92],"randomized":[58],"to":[59,226],"or":[63,245],"without":[64,136,160,185,203],"MMF.":[65,204],"Plasma":[66],"samples":[67],"for":[68,79,94],"taken":[72],"HLA-DR-CD4+":[74],"T":[75,195],"cells":[76,173,180,196],"co-cultured":[78],"isolation.":[81],"Slopes":[82],"viral":[89],"load":[90],"calculated":[93],"first":[96,101],"14":[97],"days":[98],"24":[102],"weeks":[103],"treatment,":[105],"respectively.":[106],"RESULTS:":[107],"The":[108,165,191,222],"median":[109,166],"daily":[113,167],"chronically":[117],"was":[120,146,174,197,209],"0.25":[121],"log10":[122,132,148,156],"copies/ml":[123,133,149,157],"[interquartile":[124],"range":[125],"(IQR),":[126],"0.18-0.30]":[127],"MMF":[129,137,153,161,225],"0.28":[131],"(IQR,":[134,150,158],"0.22-0.32)":[135],"(P":[138,162,188],"=":[139,163,189],"0.56);":[140],"patients,":[144],"it":[145],"0.31":[147],"0.31-0.32)":[151],"0.32":[155],"0.26-0.34)":[159],"0.75).":[164],"0.017":[175],"0.004":[177],"cells/10":[179],"MMF,":[186,207],"respectively":[187],"0.89).":[190],"increase":[192,211,238],"CD4":[194],"comparable":[198],"between":[199],"After":[205],"stopping":[206],"there":[208],"an":[210],"six":[217],"eight":[219],"patients.":[220],"CONCLUSION:":[221],"addition":[223],"class":[229],"does":[235],"not":[236],"significantly":[237],"reservoir.":[254]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}